1	New	new	_	_	_	_	_	_	_
2	immunosuppressive	immunosuppressive	_	_	_	_	_	_	_
3	drug	drug	_	_	_	_	_	_	_
4	PNU156804	pnu156804	_	_	_	_	_	_	_
5	blocks	block	_	_	_	_	_	_	_
6	IL-2-dependent	il-2-dependent	_	_	_	_	_	_	_
7	proliferation	proliferation	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	NF-kappa	NF-kappa	_	_	_	_	_	_	_
10	B	B	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	AP-1	ap-1	_	_	_	_	_	_	_
13	activation	activation	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	had	have	_	_	_	_	_	_	_
3	previously	previously	_	_	_	_	_	_	_
4	shown	show	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	drug	drug	_	_	_	_	_	_	_
8	undecylprodigiosin	undecylprodigiosin	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	UP	up	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	blocks	block	_	_	_	_	_	_	_
13	human	human	_	_	_	_	_	_	_
14	lymphocyte	lymphocyte	_	_	_	_	_	_	_
15	proliferation	proliferation	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	vitro	vitro	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	now	now	_	_	_	_	_	_	_
4	investigated	investigate	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	mechanism	mechanism	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	action	action	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	new	new	_	_	_	_	_	_	_
12	analogue	analogue	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	UP	up	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	PNU156804	PNU156804	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	which	which	_	_	_	_	_	_	_
19	shows	show	_	_	_	_	_	_	_
20	a	a	_	_	_	_	_	_	_
21	more	more	_	_	_	_	_	_	_
22	favorable	favorable	_	_	_	_	_	_	_
23	activity	activity	_	_	_	_	_	_	_
24	profile	profile	_	_	_	_	_	_	_
25	than	than	_	_	_	_	_	_	_
26	UP	up	_	_	_	_	_	_	_
27	in	in	_	_	_	_	_	_	_
28	mice	mouse	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	demonstrate	demonstrate	_	_	_	_	_	_	_
3	here	here	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	biological	biological	_	_	_	_	_	_	_
7	effect	effect	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	PNU156804	pnu156804	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	vitro	vitro	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	indistinguishable	indistinguishable	_	_	_	_	_	_	_
14	from	from	_	_	_	_	_	_	_
15	UP	up	_	_	_	_	_	_	_
16	:	:	_	_	_	_	_	_	_
17	PNU156804	pnu156804	_	_	_	_	_	_	_
18	blocks	block	_	_	_	_	_	_	_
19	human	human	_	_	_	_	_	_	_
20	T	t	_	_	_	_	_	_	_
21	cell	cell	_	_	_	_	_	_	_
22	proliferation	proliferation	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	mid-late	mid-late	_	_	_	_	_	_	_
25	G1	g1	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	as	as	_	_	_	_	_	_	_
28	determined	determine	_	_	_	_	_	_	_
29	by	by	_	_	_	_	_	_	_
30	cell	cell	_	_	_	_	_	_	_
31	cycle	cycle	_	_	_	_	_	_	_
32	analysis	analysis	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	expression	expression	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	cyclins	cyclin	_	_	_	_	_	_	_
37	,	,	_	_	_	_	_	_	_
38	and	and	_	_	_	_	_	_	_
39	cyclin-dependent	cyclin-dependent	_	_	_	_	_	_	_
40	kinases	kinase	_	_	_	_	_	_	_
41	and	and	_	_	_	_	_	_	_
42	retinoblastoma	retinoblastoma	_	_	_	_	_	_	_
43	phosphorylation	phosphorylation	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	we	we	_	_	_	_	_	_	_
5	show	show	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	PNU156804	pnu156804	_	_	_	_	_	_	_
8	does	do	_	_	_	_	_	_	_
9	not	not	_	_	_	_	_	_	_
10	block	block	_	_	_	_	_	_	_
11	significantly	significantly	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	induction	induction	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	either	either	_	_	_	_	_	_	_
16	IL-2	il-2	_	_	_	_	_	_	_
17	or	or	_	_	_	_	_	_	_
18	IL-2R	il-2r	_	_	_	_	_	_	_
19	alpha-	alpha-	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	gamma-chains	gamma-chain	_	_	_	_	_	_	_
22	but	but	_	_	_	_	_	_	_
23	inhibits	inhibit	_	_	_	_	_	_	_
24	IL-2-dependent	il-2-dependent	_	_	_	_	_	_	_
25	T	t	_	_	_	_	_	_	_
26	cell	cell	_	_	_	_	_	_	_
27	proliferation	proliferation	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	investigated	investigate	_	_	_	_	_	_	_
4	several	several	_	_	_	_	_	_	_
5	molecular	molecular	_	_	_	_	_	_	_
6	pathways	pathway	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	are	be	_	_	_	_	_	_	_
9	known	know	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	be	be	_	_	_	_	_	_	_
12	activated	activate	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	IL-2	il-2	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	T	t	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	show	show	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	PNU156804	pnu156804	_	_	_	_	_	_	_
5	does	do	_	_	_	_	_	_	_
6	not	not	_	_	_	_	_	_	_
7	inhibit	inhibit	_	_	_	_	_	_	_
8	c-myc	c-myc	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	bcl-2	bcl-2	_	_	_	_	_	_	_
11	mRNA	mrna	_	_	_	_	_	_	_
12	induction	induction	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	On	on	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	other	other	_	_	_	_	_	_	_
4	hand	hand	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	PNU156804	PNU156804	_	_	_	_	_	_	_
7	efficiently	efficiently	_	_	_	_	_	_	_
8	inhibits	inhibit	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	activation	activation	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	NF-kappa	NF-kappa	_	_	_	_	_	_	_
14	B	B	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	AP-1	ap-1	_	_	_	_	_	_	_
17	transcription	transcription	_	_	_	_	_	_	_
18	factors	factor	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	PNU156804	pnu156804	_	_	_	_	_	_	_
2	inhibition	inhibition	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	NF-kappa	NF-kappa	_	_	_	_	_	_	_
5	B	B	_	_	_	_	_	_	_
6	activation	activation	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	due	due	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	inhibition	inhibition	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	degradation	degradation	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	I	i	_	_	_	_	_	_	_
17	kappa	kappa	_	_	_	_	_	_	_
18	B-alpha	B-alpha	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	I	i	_	_	_	_	_	_	_
21	kappa	kappa	_	_	_	_	_	_	_
22	B-beta	B-beta	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	PNU156804	pnu156804	_	_	_	_	_	_	_
2	action	action	_	_	_	_	_	_	_
3	is	be	_	_	_	_	_	_	_
4	restricted	restricted	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	some	some	_	_	_	_	_	_	_
7	signaling	signaling	_	_	_	_	_	_	_
8	pathways	pathway	_	_	_	_	_	_	_
9	;	;	_	_	_	_	_	_	_
10	it	it	_	_	_	_	_	_	_
11	does	do	_	_	_	_	_	_	_
12	not	not	_	_	_	_	_	_	_
13	affect	affect	_	_	_	_	_	_	_
14	NF-kappa	NF-kappa	_	_	_	_	_	_	_
15	B	B	_	_	_	_	_	_	_
16	activation	activation	_	_	_	_	_	_	_
17	by	by	_	_	_	_	_	_	_
18	PMA	PMA	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	T	t	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	but	but	_	_	_	_	_	_	_
23	blocks	block	_	_	_	_	_	_	_
24	that	that	_	_	_	_	_	_	_
25	induced	induce	_	_	_	_	_	_	_
26	by	by	_	_	_	_	_	_	_
27	CD40	cd40	_	_	_	_	_	_	_
28	cross-linking	cross-linking	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	B	B	_	_	_	_	_	_	_
31	lymphocytes	lymphocyte	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	conclude	conclude	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	prodigiosin	prodigiosin	_	_	_	_	_	_	_
6	family	family	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	immunosuppressants	immunosuppressant	_	_	_	_	_	_	_
9	is	be	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	new	new	_	_	_	_	_	_	_
12	family	family	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	molecules	molecule	_	_	_	_	_	_	_
15	that	that	_	_	_	_	_	_	_
16	show	show	_	_	_	_	_	_	_
17	a	a	_	_	_	_	_	_	_
18	novel	novel	_	_	_	_	_	_	_
19	target	target	_	_	_	_	_	_	_
20	specificity	specificity	_	_	_	_	_	_	_
21	clearly	clearly	_	_	_	_	_	_	_
22	distinct	distinct	_	_	_	_	_	_	_
23	from	from	_	_	_	_	_	_	_
24	that	that	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	other	other	_	_	_	_	_	_	_
27	immunosuppressive	immunosuppressive	_	_	_	_	_	_	_
28	drugs	drug	_	_	_	_	_	_	_
29	such	such	_	_	_	_	_	_	_
30	as	as	_	_	_	_	_	_	_
31	cyclosporin	cyclosporin	_	_	_	_	_	_	_
32	A	A	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	FK506	FK506	_	_	_	_	_	_	_
35	,	,	_	_	_	_	_	_	_
36	and	and	_	_	_	_	_	_	_
37	rapamycin	rapamycin	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

